Gerald A. Posen

2.1k total citations · 1 hit paper
33 papers, 1.6k citations indexed

About

Gerald A. Posen is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Gerald A. Posen has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Gerald A. Posen's work include Dialysis and Renal Disease Management (16 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Erythropoietin and Anemia Treatment (7 papers). Gerald A. Posen is often cited by papers focused on Dialysis and Renal Disease Management (16 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Erythropoietin and Anemia Treatment (7 papers). Gerald A. Posen collaborates with scholars based in Canada, United States and India. Gerald A. Posen's co-authors include David Churchill, P Cartier, Paul E. Barré, Marc B. Goldstein, D. Wayne Taylor, Patricia LaPlante, Patrick S. Parfrey, Henry Mandin, William P. Fay and Kailash Jindal and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Kidney International.

In The Last Decade

Gerald A. Posen

33 papers receiving 1.4k citations

Hit Papers

Canadian Hemodialysis Morbidity Study 1992 2026 2003 2014 1992 100 200 300 400

Peers

Gerald A. Posen
J. Bommer Germany
A. M. Brownjohn United Kingdom
James Ebben United States
E. Lars Penne Netherlands
Sean F. Leavey United States
J. Bommer Germany
Gerald A. Posen
Citations per year, relative to Gerald A. Posen Gerald A. Posen (= 1×) peers J. Bommer

Countries citing papers authored by Gerald A. Posen

Since Specialization
Citations

This map shows the geographic impact of Gerald A. Posen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald A. Posen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald A. Posen more than expected).

Fields of papers citing papers by Gerald A. Posen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald A. Posen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald A. Posen. The network helps show where Gerald A. Posen may publish in the future.

Co-authorship network of co-authors of Gerald A. Posen

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald A. Posen. A scholar is included among the top collaborators of Gerald A. Posen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald A. Posen. Gerald A. Posen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cournoyer, Denis, Edwin B. Toffelmire, George A. Wells, et al.. (2004). Anti-Erythropoietin Antibody-Mediated Pure Red Cell Aplasia after Treatment with Recombinant Erythropoietin Products. Journal of the American Society of Nephrology. 15(10). 2728–2734. 58 indexed citations
2.
Zimmerman, Deborah, Peter Swedko, Gerald A. Posen, & Kevin D. Burns. (2002). DAILY HEMOFILTRATION WITH A SIMPLIFIED METHOD OF DELIVERY. ASAIO Journal. 48(2). 182–182. 15 indexed citations
3.
Beathard, Gerald A. & Gerald A. Posen. (2000). Initial clinical results with the LifeSiteR Hemodialysis Access System. Kidney International. 58(5). 2221–2227. 5 indexed citations
4.
Beathard, Gerald A. & Gerald A. Posen. (2000). Initial clinical results with the LifeSite® Hemodialysis Access System. Kidney International. 58(5). 2221–2227. 26 indexed citations
5.
Foley, Robert N., Patrick S. Parfrey, Janet Morgan, et al.. (2000). Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney International. 58(3). 1325–1335. 318 indexed citations
6.
Posen, Gerald A., et al.. (1998). Accuracy and precision of access recirculation measurements by the hemodynamic recirculation monitor. American Journal of Kidney Diseases. 31(2). 242–249. 7 indexed citations
7.
Lindsay, Robert M., et al.. (1997). Hemodialysis access blood flow rates can be measured by a differential conductivity technique and are predictive of access clotting. American Journal of Kidney Diseases. 30(4). 475–482. 66 indexed citations
8.
Goldstein, Mary K., et al.. (1995). Effect of recombinant human erythropoietin on hospitalization of hemodialysis patients.. PubMed. 43(3). 184–8. 34 indexed citations
9.
Churchill, David, et al.. (1994). Probability of thrombosis of vascular access among hemodialysis patients treated with recombinant human erythropoietin.. Journal of the American Society of Nephrology. 4(10). 1809–1813. 54 indexed citations
10.
Churchill, David, D. Wayne Taylor, Richard J. Cook, et al.. (1992). Canadian Hemodialysis Morbidity Study. American Journal of Kidney Diseases. 19(3). 214–234. 449 indexed citations breakdown →
11.
Muirhead, Norman, David Churchill, Marc B. Goldstein, et al.. (1992). Comparison of Subcutaneous and Intravenous Recombinant Human Erythropoietin for Anemia in Hemodialysis Patients with Significant Comorbid Disease. American Journal of Nephrology. 12(5). 303–310. 54 indexed citations
12.
Cole, Edward, Daniel C. Cattran, Alexander Magil, et al.. (1992). A Prospective Randomized Trial of Plasma Exchange as Additive Therapy in Idiopathic Crescentic Glomerulonephritis. American Journal of Kidney Diseases. 20(3). 261–269. 104 indexed citations
13.
Posen, Gerald A., John Jeffery, Stanley S.A. Fenton, & Gerald S. Arbus. (1990). Results From the Canadian Renal Failure Registry. American Journal of Kidney Diseases. 15(5). 397–401. 19 indexed citations
14.
Fortier, Lisa A., et al.. (1989). Mortality rates among patients with end-stage renal disease in Canada, 1981-86.. PubMed. 141(7). 677–82. 10 indexed citations
15.
Posen, Gerald A., et al.. (1980). Continuous Equllibration Peritoneal Dialysis in the Treatment of Acute Renal Fallure. Peritoneal Dialysis International. 1(2). 6–7. 14 indexed citations
16.
Jetté, M, et al.. (1977). Effects of an exercise programme in a patient undergoing hemodialysis treatment.. PubMed. 17(2). 181–6. 12 indexed citations
17.
Rashid, Abdur, et al.. (1977). HEPATITIS B ANTIGEN INFECTION AND GRAFT SURVIVAL IN CADAVERIC RENAL TRANSPLANTATION. ASAIO Journal. 23(1). 433–435. 4 indexed citations
18.
Posen, Gerald A., et al.. (1974). Accumulation of Lymph Around the Transplanted Kidney (Lymphocele) Mimicking Renal Allograft Rejection. The Journal of Urology. 111(2). 145–147. 30 indexed citations
19.
Hartitzsch, B. von, Nicholas A. Hoenich, R. John Leigh, et al.. (1972). Permanent Neurological Sequelae Despite Haemodialysis for Lithium Intoxication. BMJ. 4(5843). 757–759. 91 indexed citations
20.
Posen, Gerald A., et al.. (1971). IMMUNOLOGICAL DETECTION OF RENAL ALLOGRAFT REJECTION IN MAN. Transplantation. 12(5). 341–347. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026